21 Jun 2017 12:09
21 June 2017
Consort Medical plc
Notification of Transactions of Directors or
Persons Discharging Managerial Responsibility and Connected Persons
On 20 June 2017 pursuant to the rules of the Consort Medical plc Deferred Bonus Plan the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares at a share price of £10.67 ("Shares") in the Company in respect of the financial year 2016/17 as detailed against their name below:
Deferred Bonus Share Award
Director/PDMR | Number of Shares |
Jon Glenn | 15,787 |
Keyvan Djamarani | 5,230 |
Each award was granted as a nil cost option.
Enquiries: Michelle Palmer Assistant Company Secretary 01442 867920
Consort Medical plc is a leading, global, single source pharma services drug and delivery device company. We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.
Our businesses
Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, injectables and ocular products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.
Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com.
We employ more than 2000 people globally of which 1400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Jonathan Glenn
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CEO | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 15,787 | ||||
d)
| Aggregated information | n/a single transaction | |||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 20 June 2017 | |||
f)
| Place of the transaction
| Off market transaction | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Keyvan Djamarani | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Managing Director Bespak Division | |||
b)
| Initial notification /Amendment
| Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Grant of ordinary shares pursuant to the Consort Medical Deferred Bonus Plan | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 5,230 | ||||
d)
| Aggregated information | n/a single transaction | |||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 20 June 2017 | |||
f)
| Place of the transaction
| Off market transaction | |||